Tmall AI Institute and Pakistan Launch Multi-Cancer Screening AI Overseas
On March 3, 2026, Alibaba's DAMO Academy announced a series of collaborations with the government of Pakistan and multiple institutions, formalizing the introduction of its multi-cancer screening AI technology into the country through signed memoranda of understanding. Under the agreements, Capital Hospital and Khawaja Safdar Medical College will integrate this AI system into their imaging departments. The technology will assist in identifying various common cancers, including pancreatic, gastric, colorectal, and esophageal cancer, as well as chronic conditions like fatty liver. Pakistan's largest cloud provider, Sky47, will provide the underlying infrastructure and deployment support necessary for the technology's large-scale application.

This partnership signifies the deepening reach of China's medical AI technology in Belt and Road Initiative countries. The DAMO Academy-developed system utilizes computer vision and deep learning algorithms to help doctors identify subtle lesions that are difficult for the human eye to detect, aiming to improve early detection rates and the timeliness of treatment. Currently, this multi-cancer screening AI service is operational in medical institutions across 10 countries and regions globally, serving over 20 million people.
From an industry perspective, medical AI is evolving from single-disease screening toward comprehensive multi-disease joint diagnosis. The initiative's deployment in Pakistan not only validates the cross-regional applicability of Chinese AI models in complex medical environments but also showcases the significant potential of the "AI + Cloud" collaboration model in enhancing digital health standards in regions with underdeveloped medical infrastructure. This model of technology export is increasingly recognized as a vital component of global public health governance.
Related article
Uber Engineer Creates AI Clone of CEO to Dodge Direct Questions
While most staff dread reporting to the CEO, engineers at global travel leader Uber have discovered a strategic advantage: letting an AI replica of their boss provide feedback beforehand."Dara AI": The Executive Coach Before Boardroom MeetingsUber CE
How Unitree is Shaping the Future of Humanoid Robotics
Unitree’s New Creature of Embodied AI with ultra-wide 4D LiDAR technology for advanced real-world navigation. Credit: UnitreeWang Xingxing, CEO of Unitree, targets world model breakthroughs to help humanoid machines execute 80% of tasks when placed i
Why Abnormal AI Partnered With OpenAI on Daybreak
Michael Aiello, Head of Product for Cyber at OpenAI | Credit: Michael Aiello/LinkedInAbnormal AI joins OpenAI’s Daybreak programme, as Mike Aiello says the partnership will accelerate the adoption of practical defences for enterprisesLeading frontier
Related Special Topic Recommendations
Comments (1)
0/500
Interessant, dass Alibaba seine KI-Krebsfrüherkennung jetzt in Pakistan einführt. Hoffentlich wird die Technologie dort wirklich zugänglich und bezahlbar für die Bevölkerung sein, nicht nur ein Prestigeprojekt. Die Datenfrage macht mir aber etwas Sorgen – wo landen die medizinischen Daten der Patienten? 🤔
On March 3, 2026, Alibaba's DAMO Academy announced a series of collaborations with the government of Pakistan and multiple institutions, formalizing the introduction of its multi-cancer screening AI technology into the country through signed memoranda of understanding. Under the agreements, Capital Hospital and Khawaja Safdar Medical College will integrate this AI system into their imaging departments. The technology will assist in identifying various common cancers, including pancreatic, gastric, colorectal, and esophageal cancer, as well as chronic conditions like fatty liver. Pakistan's largest cloud provider, Sky47, will provide the underlying infrastructure and deployment support necessary for the technology's large-scale application.

This partnership signifies the deepening reach of China's medical AI technology in Belt and Road Initiative countries. The DAMO Academy-developed system utilizes computer vision and deep learning algorithms to help doctors identify subtle lesions that are difficult for the human eye to detect, aiming to improve early detection rates and the timeliness of treatment. Currently, this multi-cancer screening AI service is operational in medical institutions across 10 countries and regions globally, serving over 20 million people.
From an industry perspective, medical AI is evolving from single-disease screening toward comprehensive multi-disease joint diagnosis. The initiative's deployment in Pakistan not only validates the cross-regional applicability of Chinese AI models in complex medical environments but also showcases the significant potential of the "AI + Cloud" collaboration model in enhancing digital health standards in regions with underdeveloped medical infrastructure. This model of technology export is increasingly recognized as a vital component of global public health governance.
Uber Engineer Creates AI Clone of CEO to Dodge Direct Questions
While most staff dread reporting to the CEO, engineers at global travel leader Uber have discovered a strategic advantage: letting an AI replica of their boss provide feedback beforehand."Dara AI": The Executive Coach Before Boardroom MeetingsUber CE
How Unitree is Shaping the Future of Humanoid Robotics
Unitree’s New Creature of Embodied AI with ultra-wide 4D LiDAR technology for advanced real-world navigation. Credit: UnitreeWang Xingxing, CEO of Unitree, targets world model breakthroughs to help humanoid machines execute 80% of tasks when placed i
Why Abnormal AI Partnered With OpenAI on Daybreak
Michael Aiello, Head of Product for Cyber at OpenAI | Credit: Michael Aiello/LinkedInAbnormal AI joins OpenAI’s Daybreak programme, as Mike Aiello says the partnership will accelerate the adoption of practical defences for enterprisesLeading frontier
Interessant, dass Alibaba seine KI-Krebsfrüherkennung jetzt in Pakistan einführt. Hoffentlich wird die Technologie dort wirklich zugänglich und bezahlbar für die Bevölkerung sein, nicht nur ein Prestigeprojekt. Die Datenfrage macht mir aber etwas Sorgen – wo landen die medizinischen Daten der Patienten? 🤔





Home






